Retatrutide Dosing Guide: How to Titrate and When to Move Up

This article describes what published trials tested and what people on retatrutide have shared about their experience. It is educational, not medical advice or a treatment recommendation.

Quick answer

People generally start thinking about the next dose step once side effects from their current dose have settled (usually around weeks 3 to 4) and weight loss has plateaued for 2 to 3 weeks at steady eating. Common reasons people delay a dose change: side effects have not settled, weight loss is still happening, eating drifted up over the past month, or labs show concerning changes. For plateaus specifically: track what you are actually eating for two weeks first. If your intake crept up, that is the issue. If it did not, the dose has likely hit its ceiling. The actual call is yours and your prescriber's.

You started retatrutide, or you are a few weeks in, and you are trying to figure out: when do I move up? Side effects are settling, the scale is not moving like it was, and you do not know if it is time to escalate or hold.

When people move up

Most people who end up moving to the next dose have first settled into a rhythm at their current dose: they feel okay day to day and have seen at least two weeks of flat weight at steady eating. Whether that is the right call for you is between you and your prescriber.

Some signals point in the direction of moving up. Others point toward holding.

Signal	Lean toward the next dose	Lean toward holding
How current side effects feel	Settled, manageable for a few weeks	Still rough after 3 weeks at this dose
Weight trend	Plateaued 2 to 3 weeks at steady eating	Still moving downward
Honest eating tracking	Steady for at least 2 weeks	Drifted up over the past month
Energy, sleep, mood	Stable	Crashing
Recent labs	Within your prescriber's range	Showing concerning changes
Life context	Stable for the next few weeks	Travel, surgery, or big stress incoming

The plateau question: is it the drug or is it you?

This is where most people get stuck. The scale stops moving and the first instinct is to ask the prescriber about going up. Sometimes that is right. Sometimes it is not.

Two completely different things look the same on the scale:

It is the drug. You feel okay, side effects are minimal, your eating has been consistent with what you have been doing for the past month, your activity is consistent, and you are just not losing anymore. The drug is doing what it can at this dose. A dose increase actually moves the needle.

It is you. You feel okay, side effects are minimal, but if you are honest with yourself, your eating has crept back up over the past month. Maybe a slightly bigger dinner here, a few more snacks there. The appetite suppression is not biting as hard as it used to. The drug is still working. You stopped pushing the deficit. A dose increase does not fix this. Tightening your nutrition does.

Telling them apart is not complicated. Track what you are actually eating for two weeks. If your intake crept up, that is where to start. If your intake is steady and you are still not losing, this is the kind of pattern worth bringing to your prescriber.

Most people skip the tracking-honestly step. Many of them blame the drug for what is actually a slow lifestyle drift.

What the Phase 2 trial used

The Phase 2 retatrutide trial published by Eli Lilly in 2023 (Jastreboff et al., NEJM) tested four maintenance doses against placebo. Weight loss at 48 weeks:

Dose tested	Weight loss at 48 weeks
1 mg/week	About 9%
4 mg/week	About 17%
8 mg/week	About 23%
12 mg/week	About 24%
Placebo	About 2%

Most of the weight loss happens in the first six months and then continues at a slower pace. The trial titrated participants up to their assigned dose over the first several weeks, with the most common side effects (nausea, vomiting, diarrhea, constipation) clustered around the escalation period.

In real-world use, people often titrate slower than the trial, hold each step longer, and sometimes stop escalating once they find a dose that is giving steady results with manageable side effects. The trial schedule is one reference point. Your prescriber sets the schedule for you.

How side effects play out

A large analysis of GLP-1 user posts found that about 44% of users report at least one side effect. The most common across the class:

Side effect	About how often reported
Nausea	37%
Fatigue	17%
Vomiting	16%
Constipation	15%
Diarrhea	13%

Women also report menstrual changes and feeling colder or warmer than usual.

When they hit during titration:

Week 1 after a dose change. Side effects spike. Nausea sharpest, fatigue hardest, sleep often weird.
Week 2. Things start to settle. Appetite suppression deepens.
Weeks 3 to 4. New baseline. Side effects either resolve to something tolerable or they do not.

If you are still in active side-effect spike at week 3, the dose ramped too fast for you. This is the kind of pattern people often bring up with their prescriber. If by week 4 weight is not moving, the current dose may have hit its ceiling.

Labs people often pull

These are the labs people commonly track on retatrutide:

Lab	Why it matters
HbA1c	Shows average blood sugar over the past 3 months. Useful even without diabetes since GLP-1 drugs affect insulin sensitivity.
Fasting glucose	A snapshot of where your blood sugar sits when you have not eaten.
Lipid panel (LDL, HDL, triglycerides)	GLP-1 drugs shift cholesterol numbers, often in good directions.
Hematocrit	Red blood cell concentration. Useful especially if you are on TRT alongside retatrutide.
Thyroid panel	If you have symptoms (fatigue, cold intolerance, hair changes) that could overlap with side effects.

Most people pull labs around week 8 to 12 after starting, then before any meaningful dose change. Using the same panel each time makes the trend visible.

Common mistakes

Weighing every day. Daily weight is mostly noise. Water shifts, sodium, sleep, and cycle timing for women all move daily weight by a pound or two. Weekly in the same conditions is the right resolution. You will be saner.

Powering through bad side effects. Three weeks of feeling miserable at a dose is usually a sign the dose is too much too fast. Holding or stepping down is not failure. It is how people stay on the drug long enough to actually benefit.

Maxing out the dose because higher must be better. A dose someone can stay on for a year is better than a dose that wrecks them in a month. The 12 mg arm lost the most weight in trials but also had the worst side effects. The right dose is the one that gives the result you want with side effects you can live with.

Eating too little without noticing. Retatrutide kills appetite. Plenty of people drop from 2,000 calories a day to 800 or 1,000 without realizing. Under-eating tanks energy, mood, and sleep, makes side effects worse, and eventually slows fat loss because the body starts conserving. Protein is non-negotiable.

Skipping labs. GLP-1 drugs cause real metabolic and lipid shifts. Labs at week 8 to 12 and then every few months tell you what is actually happening inside, not just what shows on the scale.

What is worth tracking

A lot of things might be worth tracking on retatrutide. The most common:

Weight, weekly, same morning, same conditions
Daily energy
Daily sleep quality
Daily mood
Nausea, especially after a dose change
Bowel function
What you are eating, especially during plateaus
Lab results when you pull them
Any side effects worth flagging to your prescriber

The Regimen retatrutide tracker handles all of this with 50+ markers to choose from based on what is actually showing up for you (joint pain, hot flashes, mental clarity, libido, body composition, whatever matters). You can also log your blood work over time, so when your prescriber asks how your numbers have moved since the last labs, you have a clear visual instead of trying to remember. Dose changes overlay on your weight and lab data so each protocol change is visible against what actually happened. Free for one compound.

Frequently Asked Questions

When should I move up to the next dose?

People generally start thinking about the next dose step once side effects from their current dose have settled, weight has plateaued for 2 to 3 weeks at steady eating, and life context is stable. The actual call belongs to you and your prescriber.

How long does it take side effects to settle after a dose change?

For most people, week 1 is the spike, week 2 is the taper, and weeks 3 to 4 are the new baseline. If you are still rough at week 3, the dose ramped too fast.

Do I have to follow the Phase 2 trial schedule?

No. The trial used a specific schedule for research purposes. People in real-world use often titrate slower and hold each step longer. Your prescriber decides what is right for you.

Is a plateau a sign I need to go up?

Sometimes. Tracking what you are eating for two weeks first answers the question. If intake crept up, fix that. If eating is steady and you are not losing, that is the pattern worth bringing to your prescriber.

Should I push to 12 mg?

Not necessarily. The 12 mg arm lost the most weight in the trial but had the most side effects. A 4 or 8 mg dose someone can stay on for a year often delivers better long-term outcomes than a 12 mg dose that wrecks them.

When should I get labs?

Most people pull labs around week 8 to 12 after starting, then before any meaningful dose change. HbA1c, fasting glucose, lipid panel, and hematocrit at minimum. Same panel each time.

Is daily weighing really a problem?

Daily weight is mostly noise. Weekly in the same conditions gives you a cleaner picture and less anxiety.

Does Regimen handle retatrutide tracking?

Yes. The retatrutide tracker handles flexible dosing including mid-protocol changes, side effect logging across 50+ markers, blood work tracking with dose-overlay visualization, and the Signals engine that surfaces connections between what you are doing and what is actually happening. Pick whatever markers matter to you. Free for one compound.